Search results
Results from the WOW.Com Content Network
Prior to the Prescription Drug User Fee Act (PDUFA), median approval times of New Drug Applications ranged between 21 and 29 months. [2] The Prescription Drug User Fee Act was first passed in 1992 to facilitate the funding of the Food and Drug Administration while ensuring a more predictable timetable for drug approvals. [3]
Drug Manufacturer Indication Avapritinib: Blueprint Medicines Corp: metastatic gastrointestinal stromal tumor: Teprotumumab-trbw: Horizon Therapeutics: thyroid eye disease: Nintedanib: Boehringer Ingelheim: chronic fibrosing interstitial lung diseases: Ipilimumab: Bristol-Myers Squibb: hepatocellular carcinoma: Nivolumab: Bristol-Myers Squibb ...
The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines ...
The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...
In May, the Food and Drug Administration approved as many as 13 new drugs, higher than the eight approved in the same month last year.
The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company said. ... The FDA's approval is based on data from two trials involving 469 ...
The results of the testing program are codified in an FDA-approved public document that is called the product label, package insert or Full Prescribing Information. [10] The prescribing information is widely available on the web from the FDA, [11] drug manufacturers, and frequently inserted into drug packages. The main purpose of a drug label ...
The U.S. Food and Drug Administration on Thursday approved Roche's drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab, branded as PiaSky, is a monthly under-the-skin ...